Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis

ClinicalTrials.gov ID: NCT00771758

Public ClinicalTrials.gov record NCT00771758. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo- and Oxycodone Immediate Release (IR)-Controlled Study of Tapentadol IR for the Treatment of Acute Pain Caused by Vertebral Compression Fractures Associated With Osteoporosis

Study identification

NCT ID
NCT00771758
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Industry
Enrollment
108 participants

Conditions and interventions

Conditions

Interventions

  • oxycodone IR Drug
  • placebo Drug
  • tapentadol IR Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
Nov 30, 2009
Completion
Nov 30, 2009
Last update posted
May 8, 2014

2008 – 2009

United States locations

U.S. sites
37
U.S. states
15
U.S. cities
37
Facility City State ZIP Site status
Not listed Haleyville Alabama
Not listed Tallassee Alabama
Not listed Peoria Arizona
Not listed Tucson Arizona
Not listed Encinitas California
Not listed Los Gatos California
Not listed Mission Viejo California
Not listed Oakland California
Not listed Roseville California
Not listed San Diego California
Not listed Studio City California
Not listed Vista California
Not listed Bradenton Florida
Not listed Hialeah Florida
Not listed Kissimmee Florida
Not listed Miami Springs Florida
Not listed Ormond Beach Florida
Not listed Saint Cloud Florida
Not listed Vero Beach Florida
Not listed Atlanta Georgia
Not listed Gainesville Georgia
Not listed Peachtree Georgia
Not listed Savannah Georgia
Not listed Valdosta Georgia
Not listed Bloomington Illinois
Not listed South Bend Indiana
Not listed Covington Louisiana
Not listed Minneapolis Minnesota
Not listed North Massapequa New York
Not listed Hickory North Carolina
Not listed Akron Ohio
Not listed Canton Ohio
Not listed Marion Ohio
Not listed Eugene Oregon
Not listed Aiken South Carolina
Not listed Houston Texas
Not listed Mesquite Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00771758, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00771758 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →